Use of blood flow parameters to monitor or control the dosing of erythropoiesis-stimulating agents
US8536123B2 · kind B2 · utility
1Cited by
0References
3Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 9, 2009 |
| Grant date | Sep 17, 2013 |
| Priority date | — |
| Expiry date | Feb 9, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2230/207
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
A method that includes a measurement of hemoglobin or hematocrit with a measurement of hemodynamic parameters to monitor and/or control a modality of treatment of a patient suffering from anemia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.